Target Name: MFSD14B
NCBI ID: G84641
Review Report on MFSD14B Target / Biomarker Content of Review Report on MFSD14B Target / Biomarker
MFSD14B
Other Name(s): OTTHUMP00000021693 | FLJ14753 | HIATL1 | Major facilitator superfamily domain containing 14B | MF14B_HUMAN | Hippocampus abundant transcript-like protein 1 | major facilitator superfamily domain containing 14B | hippocampus abundant transcript-like 1 | Major facilitator superfamily domain-containing 14B | MGC117350

MFSD14B: A Potential Drug Target for Myostatin-Regulated Muscle Growth and Maintenance

MFSD14B (Myostatin-like protein D14B) is a protein that is expressed in various tissues throughout the body, including muscle, heart, and kidneys. It is characterized by its ability to bind to and inhibit the activity of myostatin, a protein that is involved in muscle growth and maintenance. MFSD14B has been shown to play a role in the regulation of muscle mass and function, and is potential drug target for diseases that involve muscle growth or dysfunction.

MFSD14B is a member of the myostatin-like protein family, which includes several other proteins that share similar structural features and functions. These proteins are involved in the regulation of a wide range of physiological processes, including muscle growth and maintenance, bone development and maintenance, and immune function. MFSD14B is unique, however, in its ability to interact with and inhibit the activity of myostatin, a protein that is involved in muscle growth and maintenance.

Myostatin is a transmembrane protein that is involved in the regulation of muscle growth and maintenance. It is composed of two heavy chains and two light chains, and is expressed in various tissues throughout the body, including muscle, heart, and kidney. Myostatin functions by binding to and inhibiting the activity of several different enzymes, including the protein kinase CKL3. This protein kinase is involved in the regulation of muscle growth and maintenance, and is a potential drug target for diseases that involve muscle growth or dysfunction.

MFSD14B has been shown to play a role in the regulation of myostatin activity and function. It is able to bind to and inhibit the activity of myostatin, which means that it can help to regulate the amount of muscle growth and maintenance that occurs. This is important for maintaining muscle mass and function, as muscle is essential for many aspects of physical activity and daily life.

In addition to its role in regulating myostatin activity, MFSD14B is also involved in the regulation of several other cellular processes. For example, it has been shown to play a role in the regulation of cell adhesion, a process that is important for the organization and function of tissues and organs. MFSD14B is also involved in the regulation of cell signaling, which is important for the regulation of a wide range of cellular processes, including cell growth, differentiation, and inflammation.

MFSD14B is also a potential drug target for diseases that involve muscle growth or dysfunction. For example, it has been shown to be involved in the regulation of muscle growth and maintenance in the disease myopathies, which are characterized by the loss of muscle mass and function. Additionally, MFSD14B has been shown to be involved in the regulation of muscle contractions in the disease myotonic dystrophy, which is characterized by muscle stiffness and decreased muscle function.

In conclusion, MFSD14B is a protein that is involved in the regulation of myostatin activity and function, as well as several other cellular processes. It is a potential drug target for diseases that involve muscle growth or dysfunction, and its research may help to improve our understanding of these conditions and the development of new treatments.

Protein Name: Major Facilitator Superfamily Domain Containing 14B

The "MFSD14B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MFSD14B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MFSD14CP | MFSD2A | MFSD2B | MFSD3 | MFSD4A | MFSD4A-AS1 | MFSD4B | MFSD4B-DT | MFSD5 | MFSD6 | MFSD6L | MFSD8 | MFSD9 | MGA | MGAM | MGAM2 | MGARP | MGAT1 | MGAT2 | MGAT3 | MGAT3-AS1 | MGAT4A | MGAT4B | MGAT4C | MGAT4D | MGAT4EP | MGAT4FP | MGAT5 | MGAT5B | MGC12916 | MGC15885 | MGC16025 | MGC16275 | MGC27382 | MGC2889 | MGC32805 | MGC34796 | MGC4859 | MGC70870 | MGLL | MGME1 | MGMT | MGP | MGRN1 | MGST1 | MGST2 | MGST3 | MHRT | MIA | MIA-RAB4B | MIA2 | MIA3 | MIAT | MIATNB | MIB1 | MIB2 | MICA | MICA-AS1 | MICAL1 | MICAL2 | MICAL3 | MICALCL | MICALL1 | MICALL2 | MICB | MICB-DT | MICC | MICD | MICOS10 | MICOS10-NBL1 | MICOS10P1 | MICOS13 | Microfilament-associated triple complex | MicroRNA 1273d | MicroRNA 1273f | MicroRNA 1273g | MicroRNA 3607 | MicroRNA 3653 | MicroRNA 3656 | MicroRNA 4417 | MicroRNA 4419a | MicroRNA 4459 | MicroRNA 4461 | MicroRNA 4532 | MicroRNA 4792 | MicroRNA 5095 | MicroRNA 5096 | MicroRNA 6087 | MicroRNA 6723 | MicroRNA 7641-1 | MicroRNA 7641-2 | Microtubule-Associated Protein | MICU1 | MICU2 | MICU3 | MID1 | MID1IP1 | MID1IP1-AS1 | MID2 | MIDEAS